Top Stories

• 

  Mandelson Arrested Over Alleged Epstein Leaks

  By Lucia Osborne-Crowley

  London's police force confirmed on Monday that it has arrested Peter Mandelson on suspicion of misconduct in pub...(read more)

• 

  Law 'In A Real Mess' If Mazur Ruling Upheld, CILEX Tells Court

  By William Janes

  The professional body for legal executives told a London appeals court on Monday that the "law is in a real mess...(read more)

• South Korea Wins Rethink Of $48M Hedge Fund Award

  By Eddie Beaver

  South Korea persuaded a London court on Monday to partly set aside a $48.5 million arbitration award over claims that the country's former president and senior officials unlawfully interfered in an $8 billion merger between two Samsung affiliates in 2015.

• Snooker Bodies Deny Ronnie O'Sullivan Biz £10M Cartel Claim

  By Lucia Osborne-Crowley

  Snooker's governing body and a leading promoter denied allegations on Monday that their exclusivity contracts with players amount to cartel behavior, as they sought to block disclosure in a £10.2 million ($14 million) claim from a company part-owned by Ronnie O'Sullivan.

• Broker Jailed For Fraud That Cost Aviation Industry £39M

  By Christopher Crosby

  A former airplane parts broker was sentenced on Monday to more than four years in prison for forging the certification of parts in a fraud that grounded commercial jets and cost the aviation industry £39 million ($53 million).

• Johnson Matthey Cuts Unit Sale Price To Honeywell To £1.3B

  By Najiyya Budaly

  Chemicals business Johnson Matthey said Monday that it has slashed the price for selling its catalyst technologies arm to U.S. heavyweight Honeywell to £1.33 billion ($1.6 billion) from £1.8 billion because of the "reduced profitability" of the subsidiary.

• Reality TV Stars Cop To Charges For Illegal Forex Trading Ads

  By Christopher Crosby

  A London judge on Friday fined seven reality TV stars and social media influencers for promoting an unauthorized trading scheme where they recommended high-risk financial products tied to foreign exchange rates.

• Fate Of Legal Service Models Rests On CILEX's Mazur Appeal

  By Joanne Faulkner

  The Court of Appeal will consider on Monday a challenge to a landmark ruling that restricts the conduct of litigation to authorized individuals, a case that has serious implications for the sector's long-standing business model for legal services.

• JP Morgan Fined €12.2M By ECB For Misreporting Risk

  By Alex Davidson

  The European Central Bank has fined J.P. Morgan €12.18 million ($14.35 million) for breaching reporting rules governing capital held against the risk of default, saying the company was guilty of serious negligence and had deficiencies in its internal processes.

• AI Tools Won't Mask Disclosure Failures, Lawyers Warn

  By Christopher Crosby

  New intelligence tools will save prosecutors valuable time and money in white-collar criminal cases, but the technology will also usher in an era of increasingly complex and technical fights over disclosure, lawyers say.

• Ex-Tech CEO Wins $2M For Firing Over China Deal Warnings

  By Jamie Lennox

  The former chief executive of a semiconductor business has won $2 million as a tribunal ruled that the company unfairly sacked him for blowing the whistle over the risks of increased Chinese involvement in the company.

• CJC Proposes AI Declaration For Drafting Witness Statements

  By William Janes

  Lawyers could soon be required to make declarations that witness statements for trial have not been prepared using artificial intelligence under new rules proposed by the Civil Justice Council as part of a consultation on working with the new technology.

• Guy Carpenter Can't Stop Willis Hiring In Team Poaching Row

  By Joel Poultney

  A judge ruled on Friday that Willis Re acted unlawfully in some ways when it recruited staff from rival Guy Carpenter, but refused to bar the reinsurance broker from dealing with particular clients or pursuing more hires over the alleged poaching plot.

• Pharma M&A Surge Eases Biotech VC Exit Struggles

  By Najiyya Budaly

  Big pharmaceutical companies circling mature drug candidates as they seek to fill a revenue hole of more than $200 billion — created by a looming patent cliff — might provide respite to venture capital investors that have struggled to exit biotech companies since COVID-19, experts say.